- Home
- AARD vs NB Comparison
AARD vs NB Comparison
Compare AARD & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AARD
- NB
- Stock Information
- Founded
- AARD 2017
- NB 1987
- Country
- AARD United States
- NB United States
- Employees
- AARD N/A
- NB N/A
- Industry
- AARD Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- AARD Health Care
- NB Basic Materials
- Exchange
- AARD Nasdaq
- NB Nasdaq
- Market Cap
- AARD 154.9M
- NB 139.3M
- IPO Year
- AARD 2025
- NB N/A
- Fundamental
- Price
- AARD $13.68
- NB $3.18
- Analyst Decision
- AARD Strong Buy
- NB Strong Buy
- Analyst Count
- AARD 5
- NB 2
- Target Price
- AARD $33.00
- NB $4.50
- AVG Volume (30 Days)
- AARD 84.2K
- NB 2.7M
- Earning Date
- AARD 08-14-2025
- NB 09-12-2025
- Dividend Yield
- AARD N/A
- NB N/A
- EPS Growth
- AARD N/A
- NB N/A
- EPS
- AARD N/A
- NB N/A
- Revenue
- AARD N/A
- NB N/A
- Revenue This Year
- AARD N/A
- NB N/A
- Revenue Next Year
- AARD N/A
- NB N/A
- P/E Ratio
- AARD N/A
- NB N/A
- Revenue Growth
- AARD N/A
- NB N/A
- 52 Week Low
- AARD $4.88
- NB $1.27
- 52 Week High
- AARD $19.58
- NB $4.36
- Technical
- Relative Strength Index (RSI)
- AARD N/A
- NB 55.75
- Support Level
- AARD N/A
- NB $3.13
- Resistance Level
- AARD N/A
- NB $3.41
- Average True Range (ATR)
- AARD 0.00
- NB 0.29
- MACD
- AARD 0.00
- NB 0.04
- Stochastic Oscillator
- AARD 0.00
- NB 49.54
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.